FDA taking look at cardiac stent

Nov. 14, 2005 at 7:00 PM

WASHINGTON, Nov. 14 (UPI) -- The Food and Drug Administration is examining a surgical stent after learning that a Michigan hospital stopped using the device for two weeks.

The William Beaumont Hospital in Royal Oak suspended use of Boston Scientific's Taxus stent after two patients were injured, the Wall Street Journal reported. Stents are used to prop open clogged arteries, and with the Taxus stents the wires used to insert them resisted removal.

The hospital has since resumed using the stent with no problems reported. Boston Scientific provided retraining for doctors in the use of the medical device.

However, cardiologists at Beaumont say they were shocked to learn Boston Scientific had told the FDA the problem had been resolved.

Like Us on Facebook for more stories from UPI.com  
Latest Headlines
Top Stories
Finland orders anti-tank weapon from Saab
Oil prices drop on Greek, Iran concerns
Scotland plans emergency wind energy talks
North Dakota rig data suggests stability
Activists deploy against Shell's arctic plans